Skip to main content
logo
Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.83
+0.23 (1.39%)
At close: Aug 21, 2026, 4:00 PM EDT
16.80
-0.03 (-0.20%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Rallybio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.650.860.64---
Revenue Growth
-15.11%34.91%----
Gross Profit
-16.54-17.54-38.87-53.54--
Operating Income
-25.42-31.36-57.2-78.93-67.88-45.65
Net Income
45.55-8.98-57.78-74.56-66.65-47.01
Earnings Per Share
7.99-1.59-10.61-14.75-16.76-14.74
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
92.8554.7465.51109.93168.99175.33
Total Debt
-0.180.150.390.56-
Net Cash (Debt)
92.8554.5665.36109.54168.44175.33
Net Cash Growth
103.21%-16.52%-40.33%-34.97%-3.93%25.03%
Net Cash Per Share
16.289.6912.0121.6742.3554.97

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
26.71-29.81-49.28-60.27-57.28-45.53
Capital Expenditures
----0.01-0.05-0.33
Free Cash Flow
26.71-29.81-49.28-60.28-57.34-45.87
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-3935.45%-3655.48%-8993.08%---
Pretax Margin
7256.19%-1046.39%-9084.12%---
Profit Margin
7051.24%-1046.39%-9084.12%---
FCF Margin
4134.99%-3474.71%-7748.74%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
138.3533.7862.62---